Stock Events

Stock Events

NewAmsterdam Pharma Company NV (NAMS) Q4 2024 Earnings

6NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-1.06

-0.71

-0.35

0

Details

Expected EPS

-0.499222

Actual EPS

-0.18

Surprise EPS

0.32

Surprise Percent

+63.94%

Description

NewAmsterdam Pharma Company NV (NAMS) has reported earnings of -0.18 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.